STC2 and Stroke: Administration of ASA for short time periods (less than a year of medication with 100 mg on a daily basis) did not statistically modify the STC2 expression values observed in the stroke/ictus patient group, despite reduced STC2 expression being found in comparison to other drugs (Figure 2B).